Breaking News

PPD Appoints Biomarker Lab Director

By Kristin Brooks | February 26, 2014

Bennett brings 25 years of lab and biomarker experience

Patrick Bennett has been appointed executive director of lab operations for PPD’s new biomarker services division of its bioanalytical lab. PPD’s bioanalytical labs facilities in Richmond, VA, and Middleton, WI, provide customized biomarker measurement, comprehensive assay development, method development, validation, transfer and sample analysis, validated methods to quantitatively measure all types of compounds, chromatography, immunochemistry, and metabolite identification.
 
Mr. Bennett joins the company from Thermo Fisher Scientific, where he served as global strategic marketing director for pharma/biopharma life sciences mass spectrometry, and led efforts to develop, manage and implement marketing strategies. Prior to that, he served as vice president of business development and marketing and executive lab director at Tandem Labs, where he managed scientific and regulatory leadership activities.
 
“Patrick brings more than 25 years of experience in laboratories and biomarker services,” said David Johnston, Ph.D., PPD’s executive vice president of global laboratory services. “At PPD, our bioanalytical labs provide state-of-the-art facilities and instrumentation, scientific expertise, experienced regulatory staff and capabilities in a wide variety of technologies and methods. Patrick will lead and drive strategy for comprehensive biomarker development and testing from discovery through approval of predictive medicine biomarkers for both large and small molecule therapeutics.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.